Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2024 12:38 ET | Source: The Rosen Law Firm PA

CKPT SHAREHOLDER ALERT: TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March...
November 22, 2022 12:00 ET | Source: Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals Elargit son Portefeuille de Produits avec un Spray Nasal pour la Rhinite Idiopathique

Hyloris Pharmaceuticals Elargit son Portefeuille de Produits avec un Produit Candidat Intranasal Propriétaire d'un Agoniste TRPV11 (HY-083) pour la Rhinite Idiopathique - Hyloris cible une...
November 22, 2022 12:00 ET | Source: Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals Broadens Pipeline with a Nasal Product Candidate for Idiopathic Rhinitis

Hyloris Pharmaceuticals Broadens Pipeline with a Proprietary Intranasal Product Candidate of a TRPV11 agonist (HY-083) for Idiopathic Rhinitis Hyloris targets a condition that affects up to 7% of...
July 11, 2019 17:28 ET | Source: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the...